Betulinic acid ameliorates endothelium-dependent relaxation in L-NAME-induced hypertensive rats by reducing oxidative stress. 2011

Jia-Yin Fu, and Ling-Bo Qian, and Lie-Gang Zhu, and Hao-Te Liang, and Yi-Nuo Tan, and Han-Ti Lu, and Jian-Feng Lu, and Hui-Ping Wang, and Qiang Xia
Department of Physiology, Zhejiang University School of Medicine, Hangzhou 310058, China.

Zizyphi Spinosi semen (ZSS) is one of the most widely used traditional Chinese herbs with protective effects on the cardiovascular system. It is not clear whether betulinic acid (BA), the key active constituent of ZSS, has beneficial cardiovascular effects on N(ω)-nitro-L-arginine methyl ester hydrochloride (L-NAME)-induced hypertensive rats. The objective of this study was to investigate the effect of BA on endothelium-dependent vasorelaxation in isolated aortic rings from L-NAME-induced hypertensive rats and its underlying mechanisms. Male Sprague-Dawley rats were injected with L-NAME (15 mg/kg/d, i.p.) for 4 weeks to induce hypertension. After treatment with L-NAME for 2 weeks, rats with mean blood pressure >120 mm Hg measured by tail-cuff method were considered hypertensive and then injected with BA (0.8, 4, 20 mg/kg/d, i.p.) for the last 2 weeks. The effect of BA on the tension of rat thoracic aortic rings was measured in an organ bath system. The levels of nitric oxide (NO), reactive oxygen species (ROS), and the activity of superoxide dismutase (SOD) and nitric oxide synthase (NOS) in aortas were assayed. We found that BA (0.1-100 μM) evoked a concentration-dependent vasorelaxation in endothelium-intact normal rat aortic rings, which was significantly attenuated by pretreatment with L-NAME (100 μM) or methylene blue (MB, 10 μM), but not by indomethacin (10 μM). Pretreatment with EC(50) (1.67 μM) concentration of BA enhanced the acetylcholine (ACh)-induced vasorelaxation, which was also markedly reversed by both L-NAME and MB. The blood pressure in hypertensive rats increased to 135.22±5.38 mm Hg (P<0.01 vs. control group), which was markedly attenuated by high dose of BA. The ACh-induced vasorelaxation in hypertensive rat aortic rings was impaired, which was markedly improved by chronic treatment with BA (20 mg/kg/d) for 2 weeks. The increase of ROS level and the decrease of NO level, SOD and eNOS activities in hypertensive rat aortas were all markedly inhibited by BA. These results indicate that BA decreased blood pressure and improved ACh-induced endothelium-dependent vasorelaxation in L-NAME-induced hypertension rats, which may be mediated by reducing oxidative stress and retaining the bioavailability of NO in the cardiovascular system.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D009569 Nitric Oxide A free radical gas produced endogenously by a variety of mammalian cells, synthesized from ARGININE by NITRIC OXIDE SYNTHASE. Nitric oxide is one of the ENDOTHELIUM-DEPENDENT RELAXING FACTORS released by the vascular endothelium and mediates VASODILATION. It also inhibits platelet aggregation, induces disaggregation of aggregated platelets, and inhibits platelet adhesion to the vascular endothelium. Nitric oxide activates cytosolic GUANYLATE CYCLASE and thus elevates intracellular levels of CYCLIC GMP. Endogenous Nitrate Vasodilator,Mononitrogen Monoxide,Nitric Oxide, Endothelium-Derived,Nitrogen Monoxide,Endothelium-Derived Nitric Oxide,Monoxide, Mononitrogen,Monoxide, Nitrogen,Nitrate Vasodilator, Endogenous,Nitric Oxide, Endothelium Derived,Oxide, Nitric,Vasodilator, Endogenous Nitrate
D003627 Data Interpretation, Statistical Application of statistical procedures to analyze specific observed or assumed facts from a particular study. Data Analysis, Statistical,Data Interpretations, Statistical,Interpretation, Statistical Data,Statistical Data Analysis,Statistical Data Interpretation,Analyses, Statistical Data,Analysis, Statistical Data,Data Analyses, Statistical,Interpretations, Statistical Data,Statistical Data Analyses,Statistical Data Interpretations
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D004730 Endothelium, Vascular Single pavement layer of cells which line the luminal surface of the entire vascular system and regulate the transport of macromolecules and blood components. Capillary Endothelium,Vascular Endothelium,Capillary Endotheliums,Endothelium, Capillary,Endotheliums, Capillary,Endotheliums, Vascular,Vascular Endotheliums
D000094062 Betulinic Acid A lupane-type triterpene derivative of betulin which was originally isolated from BETULA or birch tree. It has anti-inflammatory, anti-HIV and antineoplastic activities. 3-Epi-betulinic Acid,3-Hydroxy-lup-20(29)-en-28-oic Acid,3-Hydroxylup-20(29)-en-28-oic Acid,Betulic Acid,3 Epi betulinic Acid
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000959 Antihypertensive Agents Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. Anti-Hypertensive,Anti-Hypertensive Agent,Anti-Hypertensive Drug,Antihypertensive,Antihypertensive Agent,Antihypertensive Drug,Anti-Hypertensive Agents,Anti-Hypertensive Drugs,Anti-Hypertensives,Antihypertensive Drugs,Antihypertensives,Agent, Anti-Hypertensive,Agent, Antihypertensive,Agents, Anti-Hypertensive,Agents, Antihypertensive,Anti Hypertensive,Anti Hypertensive Agent,Anti Hypertensive Agents,Anti Hypertensive Drug,Anti Hypertensive Drugs,Anti Hypertensives,Drug, Anti-Hypertensive,Drug, Antihypertensive,Drugs, Anti-Hypertensive,Drugs, Antihypertensive
D001013 Aorta, Thoracic The portion of the descending aorta proceeding from the arch of the aorta and extending to the DIAPHRAGM, eventually connecting to the ABDOMINAL AORTA. Aorta, Ascending,Aorta, Descending,Aortic Arch,Aortic Root,Arch of the Aorta,Descending Aorta,Sinotubular Junction,Ascending Aorta,Thoracic Aorta,Aortic Roots,Arch, Aortic,Ascending Aortas,Junction, Sinotubular,Root, Aortic,Sinotubular Junctions

Related Publications

Jia-Yin Fu, and Ling-Bo Qian, and Lie-Gang Zhu, and Hao-Te Liang, and Yi-Nuo Tan, and Han-Ti Lu, and Jian-Feng Lu, and Hui-Ping Wang, and Qiang Xia
September 2010, Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences,
Jia-Yin Fu, and Ling-Bo Qian, and Lie-Gang Zhu, and Hao-Te Liang, and Yi-Nuo Tan, and Han-Ti Lu, and Jian-Feng Lu, and Hui-Ping Wang, and Qiang Xia
December 2012, Naunyn-Schmiedeberg's archives of pharmacology,
Jia-Yin Fu, and Ling-Bo Qian, and Lie-Gang Zhu, and Hao-Te Liang, and Yi-Nuo Tan, and Han-Ti Lu, and Jian-Feng Lu, and Hui-Ping Wang, and Qiang Xia
June 2000, General pharmacology,
Jia-Yin Fu, and Ling-Bo Qian, and Lie-Gang Zhu, and Hao-Te Liang, and Yi-Nuo Tan, and Han-Ti Lu, and Jian-Feng Lu, and Hui-Ping Wang, and Qiang Xia
December 2011, European journal of pharmacology,
Jia-Yin Fu, and Ling-Bo Qian, and Lie-Gang Zhu, and Hao-Te Liang, and Yi-Nuo Tan, and Han-Ti Lu, and Jian-Feng Lu, and Hui-Ping Wang, and Qiang Xia
October 2002, Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi,
Jia-Yin Fu, and Ling-Bo Qian, and Lie-Gang Zhu, and Hao-Te Liang, and Yi-Nuo Tan, and Han-Ti Lu, and Jian-Feng Lu, and Hui-Ping Wang, and Qiang Xia
February 2010, Nitric oxide : biology and chemistry,
Jia-Yin Fu, and Ling-Bo Qian, and Lie-Gang Zhu, and Hao-Te Liang, and Yi-Nuo Tan, and Han-Ti Lu, and Jian-Feng Lu, and Hui-Ping Wang, and Qiang Xia
March 2022, Biochimica et biophysica acta. Molecular basis of disease,
Jia-Yin Fu, and Ling-Bo Qian, and Lie-Gang Zhu, and Hao-Te Liang, and Yi-Nuo Tan, and Han-Ti Lu, and Jian-Feng Lu, and Hui-Ping Wang, and Qiang Xia
April 2001, Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi,
Jia-Yin Fu, and Ling-Bo Qian, and Lie-Gang Zhu, and Hao-Te Liang, and Yi-Nuo Tan, and Han-Ti Lu, and Jian-Feng Lu, and Hui-Ping Wang, and Qiang Xia
April 1996, American journal of hypertension,
Jia-Yin Fu, and Ling-Bo Qian, and Lie-Gang Zhu, and Hao-Te Liang, and Yi-Nuo Tan, and Han-Ti Lu, and Jian-Feng Lu, and Hui-Ping Wang, and Qiang Xia
June 2011, Molecular and cellular biochemistry,
Copied contents to your clipboard!